The Latest Antidepressants: “Must Know” Information About Vilazodone (Viibryd®), Levomilnacipran (Fetzima®), Vortioxetine (Brintellix®), and Lurasidone (Latuda®). (Series: Simple and Practical)

If a patient comes in on one the newest antidepressants OR you need to try one of them, will you know what is clinically needed or very little about them? If a drug rep tries to €œeducate€ you about one of the newest antidepressants, will you need that education and not know how to separate the facts from the hype? Or will you be an €œup-to-date clinician€ who has briefly reviewed key issues and can speak confidently about the medication?

Two problems, however. Who has time to read original papers and even complex review articles with dozens of references? Also, even if you took a week off to read the vast amount of data on these antidepressants, unless you are a researcher in this specific area and have some background in biostatistics, it is not easy to interpret the literature.

This short e-book from a leading expert in mood disorders is the solution to both these problems. He has extracted the most important information about the most recently introduced antidepressants. Everything you need but no unnecessary €œacademic€ or statistical material. Your time is valuable, so no fluff! You can read this e-book in an hour or two.

Importantly, he provides his expert opinion to guide you in interpreting the available data about these medications. What could the possible advantages of a particular antidepressant be? How to make sense of the data on a particular antidepressant? Is the data on a particular point convincing or not? Links to websites and handouts for patients are provided as well. This e-book is a must for those in the mental health field who treat patients with major depressive disorder and bipolar depression and want to be up-to-date.